Setbacks For China Pharma As Firms Hit With Antitrust Fine, Clinical Setback

 
• By Brian Yang
china and antitrust
YANGZTE RIVE PHARMA BECOMES THE TARGET IN CHINA ANTITRUST CRACKDOWN • Source: Shutterstock

More from China

More from Focus On Asia